0001493152-24-005207.txt : 20240207 0001493152-24-005207.hdr.sgml : 20240207 20240207083010 ACCESSION NUMBER: 0001493152-24-005207 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240206 FILED AS OF DATE: 20240207 DATE AS OF CHANGE: 20240207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Finley John David CENTRAL INDEX KEY: 0001851034 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33672 FILM NUMBER: 24602296 MAIL ADDRESS: STREET 1: C/O SENECA BIOPHARMA, INC. STREET 2: 20271 GOLDENROD LANE CITY: GERMANTOWN STATE: MD ZIP: 20876 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PALISADE BIO, INC. CENTRAL INDEX KEY: 0001357459 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 522007292 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7750 EL CAMINO REAL, SUITE 5200 CITY: CARLSBAD STATE: CA ZIP: 92009 BUSINESS PHONE: (858) 704-4900 MAIL ADDRESS: STREET 1: 7750 EL CAMINO REAL, SUITE 5200 CITY: CARLSBAD STATE: CA ZIP: 92009 FORMER COMPANY: FORMER CONFORMED NAME: Seneca Biopharma, Inc. DATE OF NAME CHANGE: 20200127 FORMER COMPANY: FORMER CONFORMED NAME: Neuralstem, Inc. DATE OF NAME CHANGE: 20060324 4 1 ownership.xml X0508 4 2024-02-06 0 0001357459 PALISADE BIO, INC. PALI 0001851034 Finley John David 7750 EL CAMINO REAL, SUITE 2A CARLSBAD, CA 92009 1 1 0 0 CEO, CFO, Director 0 Common Stock, par value $0.01 2024-02-06 4 P 0 10000 0.4692 A 84649 D Common Stock, par value $0.01 777 I By FCW Investments, LLC Reporting Person purchased 10,000 shares of Common Stock in open market purchase transactions ranging from $0.46 to $0.47. The Reporting Person agrees to provide full information regarding the number of shares purchased at each separate price paid if requested by the SEC Staff, the Company, or a security holder of the Company. Reporting Person is the managing member of FCW Investments LLC and has the sole investment and voting power over the securities held by this entity. /s/ JD Finley 2024-02-07